MedPath
NMPA Approval

Lornoxicam for Injection

国药准字H20244283

June 28, 2024

Drug Information

注射用氯诺昔康

注射剂

8mg

化学药品

June 28, 2024

Company Information

Applicant Company

北京市顺义区北务镇民泰路9号(科技创新功能区)

Manufacturing Company

山西省大同经济技术开发区第一医药园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用氯诺昔康 - NMPA 批准文号 | MedPath